vs
CYTOKINETICS INC(CYTK)与RBB Bancorp(RBB)财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是CYTOKINETICS INC的1.8倍($32.3M vs $17.8M),RBB Bancorp净利率更高(31.5% vs -1030.9%,领先1062.4%),RBB Bancorp同比增速更快(12.6% vs 4.9%),RBB Bancorp自由现金流更多($42.6M vs $-148.3M)
Cytokinetics是一家总部位于美国加利福尼亚州南旧金山的生物制药企业,专注于研发肌肉激活剂与肌肉抑制剂类候选药物,用于治疗以肌肉功能受损或衰退为典型特征的各类疾病,为相关患者提供潜在创新治疗方案。
RBB银行控股公司是总部位于美国的金融控股集团,旗下核心主体为皇家商业银行,主要服务亚裔社群、中小微企业、不动产投资者及零售客户,提供商业信贷、储蓄存款、财富管理等多元金融服务,业务覆盖美国沿海核心都会区。
CYTK vs RBB — 直观对比
营收规模更大
RBB
是对方的1.8倍
$17.8M
营收增速更快
RBB
高出7.7%
4.9%
净利率更高
RBB
高出1062.4%
-1030.9%
自由现金流更多
RBB
多$190.9M
$-148.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $17.8M | $32.3M |
| 净利润 | $-183.0M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -1004.6% | 39.5% |
| 净利率 | -1030.9% | 31.5% |
| 营收同比 | 4.9% | 12.6% |
| 净利润同比 | -22.0% | 132.1% |
| 每股收益(稀释后) | $-1.51 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CYTK
RBB
| Q4 25 | $17.8M | $32.3M | ||
| Q3 25 | — | $32.6M | ||
| Q2 25 | $66.8M | $35.8M | ||
| Q1 25 | — | $28.5M | ||
| Q4 24 | $16.9M | $28.7M | ||
| Q3 24 | — | $30.3M | ||
| Q2 24 | — | $27.5M | ||
| Q1 24 | — | $28.2M |
净利润
CYTK
RBB
| Q4 25 | $-183.0M | $10.2M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | $-134.4M | $9.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $-150.0M | $4.4M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $7.2M | ||
| Q1 24 | — | $8.0M |
营业利润率
CYTK
RBB
| Q4 25 | -1004.6% | 39.5% | ||
| Q3 25 | — | 40.7% | ||
| Q2 25 | -167.0% | 36.1% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | -821.4% | 17.6% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | — | 39.9% |
净利率
CYTK
RBB
| Q4 25 | -1030.9% | 31.5% | ||
| Q3 25 | — | 31.2% | ||
| Q2 25 | -201.2% | 26.1% | ||
| Q1 25 | — | 8.0% | ||
| Q4 24 | -886.3% | 15.3% | ||
| Q3 24 | — | 23.1% | ||
| Q2 24 | — | 26.4% | ||
| Q1 24 | — | 28.4% |
每股收益(稀释后)
CYTK
RBB
| Q4 25 | $-1.51 | $0.59 | ||
| Q3 25 | — | $0.59 | ||
| Q2 25 | $-1.12 | $0.52 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | $-1.26 | $0.26 | ||
| Q3 24 | — | $0.39 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | — | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $122.5M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $-659.6M | $523.4M |
| 总资产 | $1.4B | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势,按日历期对齐
现金及短期投资
CYTK
RBB
| Q4 25 | $122.5M | $212.3M | ||
| Q3 25 | — | $234.9M | ||
| Q2 25 | $74.9M | $191.9M | ||
| Q1 25 | — | $238.8M | ||
| Q4 24 | $94.9M | $257.7M | ||
| Q3 24 | — | $349.4M | ||
| Q2 24 | — | $252.8M | ||
| Q1 24 | — | — |
总债务
CYTK
RBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | $609.7M | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | $619.5M | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益
CYTK
RBB
| Q4 25 | $-659.6M | $523.4M | ||
| Q3 25 | — | $514.3M | ||
| Q2 25 | $-368.7M | $517.7M | ||
| Q1 25 | — | $510.3M | ||
| Q4 24 | $-135.4M | $507.9M | ||
| Q3 24 | — | $509.7M | ||
| Q2 24 | — | $511.3M | ||
| Q1 24 | — | $514.0M |
总资产
CYTK
RBB
| Q4 25 | $1.4B | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | $1.2B | $4.1B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $3.9B |
负债/权益比
CYTK
RBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-142.7M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-148.3M | $42.6M |
| 自由现金流率自由现金流/营收 | -835.2% | 131.8% |
| 资本支出强度资本支出/营收 | 31.8% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-438.9M | $73.5M |
8季度趋势,按日历期对齐
经营现金流
CYTK
RBB
| Q4 25 | $-142.7M | $43.4M | ||
| Q3 25 | — | $2.1M | ||
| Q2 25 | $-128.2M | $21.7M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | $-65.6M | $58.5M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $4.8M |
自由现金流
CYTK
RBB
| Q4 25 | $-148.3M | $42.6M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | $-132.4M | $21.6M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | $-66.9M | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $4.7M |
自由现金流率
CYTK
RBB
| Q4 25 | -835.2% | 131.8% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | -198.3% | 60.2% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | -395.0% | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | — | 16.6% |
资本支出强度
CYTK
RBB
| Q4 25 | 31.8% | 2.5% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | 6.2% | 0.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 7.6% | 2.7% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.5% |
现金转化率
CYTK
RBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CYTK
| Other | $9.1M | 51% |
| Collaboration Revenues | $8.7M | 49% |
RBB
暂无分部数据